Eye-Tracking in VR may detect dementia years earlier
NCT ID NCT07402356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses virtual reality and eye-tracking to measure how pupils react during memory tasks. Researchers hope to find a simple, non-invasive way to detect early cognitive decline in Alzheimer's disease, mild cognitive impairment, and depression. 140 adults will be tested at three visits over six months. No treatment is given—this is purely a measurement study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, non-invasive tool for early detection and monitoring of cognitive decline in clinics.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear differences between groups, and results may not apply to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Max Planck Institute of Psychiatry
RECRUITINGMünchen, Bavaria, 80804, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your brain help unlock Alzheimer's secrets?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Could sharing lived experiences ease the burden of dementia care?